Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s):  CRDL

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.


TSX:CRDL - Post by User

Comment by Youhillmanon Jan 01, 2021 6:52pm
167 Views
Post# 32208128

RE:CRDL...1 of 10 Cannabis Companies to be Watching in 2021....

RE:CRDL...1 of 10 Cannabis Companies to be Watching in 2021....I just reviewed the latest top 10 Cannabis picks by Jimmy Mengel (Outsiders Club) and it's interesting to note that both he and Michael Berger (technical420) have four of the same companies wIthin their top ten for 2021.

They are WEED, GWPH, IIPR and of course CRDL!

Since Mengel recommended IIPR, he's up 1143% on it! On WEED, he's up 185%.

As mentioned previously Mengel also recommended CURA and JUSH, I own both and the returns to date have been very good!

Both of these analysts are at the top of their profession in regards to the Cannabis sector, so I will follow the smart money and go with their recommendations over the naysayers on this board who don't add any value or rationale at all as to why CRDL won't be a major success story in 2021!
<< Previous
Bullboard Posts
Next >>